Metal complexes for use as dopants and other uses

US10038150B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10038150-B2
Application numberUS-201615099089-A
CountryUS
Kind codeB2
Filing dateApr 14, 2016
Priority dateFeb 25, 2011
Publication dateJul 31, 2018
Grant dateJul 31, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to electrochemical devices comprising complexes of cobalt comprising at least one ligand with a 5- or six membered, N-containing heteroring. The complex are useful as p- and n-dopants, as over of electrochemical devices, in particular in organic semiconductors. The complexes are further useful as over-discharge prevention and overvoltage protection agents.

First claim

Opening claim text (preview).

The invention claimed is: 1. A p-dopant comprising a complex of formula (XX) M(La) n (Xb) m   (XX) wherein M is selected from Cu 2+ , Pd 2+ , Au 2+ , Ag 2+ , and V 2+ ; n is an integer selected from 1, 2, 3 or 4; m is an integer selected from 0, 1, 2, or 3; La is a ligand independently selected from mono-, bi-, or tridentate ligands comprising a moiety independently selected from a moiety according to any one of formulae (XX-1)-(XX-5) and (XX-8)-(XX-69) wherein: R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 and R 12 of moieties (XX-1)-(XX-5) and (XX-8)-(XX-69) are independently selected from H, halogen, CI—, Br—, I − , —NO 2 , —OH, —NH 2 , —COOH, —CN, —OCN—, isocyanate group, sulfonyl group, from C1-C6 alkyl, C1-C6 heteroalkyl, C4-C20 aryl group, C4-C20 arylalkyl group and C4-C20 heteroaryl group, wherein heteroatom is selected from N, S, or O, said alkyl, heteroalkyl, arylalkyl and heteroaryl groups being optionally perfluorinated, and from a moiety according to any one of formulae (XXA-1) to (XXG-2) below: wherein: the dotted line represents the bond connecting the substituent of (XXA-1) to (XXG-2) on the ligand La according to any one of formulae (XX-1)-(XX-5) and (XX-8)-(XX-69); and, R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 of moieties (XXA-1) to (XXG-2) are independently selected from H, halogen, Cl − , Br − , I − , —NO 2 , —OH, —NH 2 , —COOH, —CN, —OCN − , isocyanate group, sulfonyl group and substituents comprising 1 to 40 carbons and 0 to 20 heteroatoms and/or groups selected from —O—, —C(O)—, —C(O)O—, —S—, —S(O)—, SO 2 —, —S(O) 2 O—, —N═, —P═, —NR 13 —, —PR 13 —, —P(O)(OR 13 )—, —P(O)(OR 13 )O—, —P(O)(NR 13 R 13 )—, —P(O)(NR 13 R 13 )O—, —P(O)(NR 13 R 13 )NR 13 —, —S(O)NR 13 —, and —S(O) 2 NR 13 , with R 13 being independently selected from H, C1-C6 alkyl, C4-C20 aryl group, C4-C20 arylalkyl group and C4-C20 heteroaryl group, said alkyl, arylalkyl and heteroaryl groups being optionally perfluorinated; R′ and R″ are independently selected from —CH 2 R 1 , —CHR 1 R 2 and —CR 1 R 2 R 3 , R 1 , R 2 and R 3 being defined as above; and Xb is a monodentate co-ligand independently selected from H 2 O, Cl − , Br − , I − , CN − , NCO − , NCS − , NCSe, NH 3 , NR 7 R 8 R 9 , or PR 7 R 8 R 9 , wherein R 7 , R 8 , and R 9 are selected independently from substituted or unsubstituted C1-C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, and C4 to C20 aryl. 2. The p-dopant according to claim 1 , wherein the complex of formula (XX) is under cationic form and provided with an anionic species independently selected from ClO 4 − , PF 6 − , BF 4 − , [B(CN) 4 ] − , CF 3 SO 3 − , [(CF 3 SO 2 ) 2 N] − (TFSI), [B(C 6 H 3 (m-CF 3 ) 2 ) 4 ] − , [B(C 6 F 5 ) 4 ] − , [B(C 6 H 5 ) 4 ] − , [Al(OC(CF 3 ) 3 ) 4 ] − , or [CB 11 H 12 ] − . 3. The p-dopant according to claim 1 , wherein M of the complex of formula (XX) is Cu′. 4. The p-dopant according to claim 1 , wherein n of the complex of formula (XX) is 2, 3 or 4. 5. The p-dopant according to claim 1 , wherein, provided that n of the complex of formula (XX) is 2, said La ligands of the complex of formula (XX) are identical or different from each other. 6. The p-dopant according to claim 1 , wherein m of the complex of formula (XX) is 0. 7. The p-dopant according to claim 1 , wherein La of the complex of formula (XX) is a ligand selected from a moiety according to any one of formulae (XX-1)-(XX-5) and (XX-66) to (XX-69). 8. The p-dopant according to claim 1 , wherein, provided that m is 0, the complex of formula (XX) is selected from a complex according to any one of formulae (XXIII) to (XXV) M L1 L2 L3 L4  (XXIII), wherein L1, L2, L3 and L4 are selected from monodentate ligands, M L1 L2 L3  (XXIV), wherein L1 and L2 are selected from monodentate ligands and L3 is selected from bidentate ligands, M L1 L2  (XXV), wherein L1 and L2 are selected from bidentate ligands, or L1 is selected from monodentate ligands and L2 is selected from tridentate ligands; wherein said mono-, bi-, or tridentate ligands are independently selected from La ligand. 9. The p-dopant according to claim 1 , wherein the complex of formula (XX) is selected from a complex according to any one of formulae (XXI) and (XXII) wherein, R 14 , R 15 , R 16 , R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , R 23 , R 24 , R 25 , R 26 , R 27 , R 28 and R 29 of complexes (XXI)-(XXII) are independently selected from H, halogen, CI—, Br—, I − , —NO 2 , —OH, —NH 2 , —COOH, —CN, —OCN—, isocyanate group, sulfonyl group, from C1-C6 alkyl, C1-C6 heteroalkyl, C4-C20 aryl group, C4-C20 arylalkyl group and C4-C20 heteroaryl group, wherein heteroatom is selected from N, S, or O, said alkyl, heteroalkyl, arylalkyl and heteroaryl groups being optionally perfluorinated, and from a moiety according to any one of formulae (XXA-I) to (XXG-2) below: wherein: the dotted line represents the bond connecting the substituent of (XXA-1) to (XXG-2) on the ligand La according to any one of formulae (XX-1)-(XX-5) and (XX-8)-(XX-69); and, R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 of moieties (XXA-1) to (XXG-2) are independently selected from H, halogen, Cl − , Br − , 1 − , −NO 2 , —OH, —NH 2 , —COOH, —CN, —OCN −

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10038150B2 cover?
The invention relates to electrochemical devices comprising complexes of cobalt comprising at least one ligand with a 5- or six membered, N-containing heteroring. The complex are useful as p- and n-dopants, as over of electrochemical devices, in particular in organic semiconductors. The complexes are further useful as over-discharge prevention and overvoltage protection agents.
Who is the assignee on this patent?
Ecole Polytechnique Fed Lausanne Epfl
What technology area does this patent fall under?
Primary CPC classification H01L51/0083. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).